7Baggers
 press release distribution & pr platform  ACCESS Newswire Fri, 02 May 2025 15:47:02 GMT
 Press Release Distribution & PR Platform  ACCESS Newswire Fri, 25 Apr 2025 04:45:55 GMT
 mhra approves first uk treatment for friedreich’s ataxia  The Pharma Letter Thu, 24 Apr 2025 09:46:12 GMT
 autosomal dominant polycystic kidney disease market future  openPR.com Thu, 10 Apr 2025 12:57:00 GMT
 CNS Pharmaceuticals Inc. (CNSP) reports earnings  qz.com Mon, 31 Mar 2025 07:00:00 GMT
 AKPKD Pipeline 2024: Key Companies, MOA, ROA, and Clinical  openPR.com Tue, 04 Mar 2025 08:00:00 GMT
 polycystic kidney disease pipeline 2025: fda approvals  openPR.com Wed, 26 Feb 2025 08:00:00 GMT
 reata pharmaceuticals, inc. to host earnings call  ACCESS Newswire Fri, 21 Feb 2025 06:55:53 GMT
 CEO Viehbacher Confident In Biogen’s Portfolio, But Open To Additions  insights.citeline.com Thu, 13 Feb 2025 08:00:00 GMT
 professor paola giunti wins creating impact through knowledge exchange award  UCL - London's Global University Wed, 05 Feb 2025 08:00:00 GMT
 reata pharmaceuticals inc. (reta) stock biogen deal contestable  The Market Periodical Thu, 16 Jan 2025 15:15:35 GMT
 reata completes new anti-inflammatory drugs agreement  OutSourcing-Pharma.com Thu, 28 Nov 2024 01:45:58 GMT
 reata pharmaceuticals, inc. (nasdaq: reta) shareholder class action alert  Marketscreener.com Sat, 23 Nov 2024 10:13:30 GMT
 friedreich's ataxia market to boost revenue potential,  openPR Fri, 15 Nov 2024 08:00:00 GMT
 biopharma layoffs roundup  Contract Pharma Tue, 12 Nov 2024 09:12:06 GMT
 biopharma layoffs roundup  Contract Pharma Mon, 11 Nov 2024 08:00:00 GMT
 Study says top launches were for drugs for untreated diseases  Fierce Pharma Wed, 06 Nov 2024 08:00:00 GMT
 extensive growth opportunities to be witnessed by autosomal  openPR Wed, 06 Nov 2024 08:00:00 GMT
 a halloween scare: ambiguity in loan terms  JD Supra Tue, 29 Oct 2024 07:00:00 GMT
 biopharma layoffs roundup  Contract Pharma Tue, 15 Oct 2024 07:00:00 GMT
 friedreich's ataxia market to show remarkable growth trends  openPR Tue, 03 Sep 2024 17:16:00 GMT
 biogen alert: bragar eagel & squire, p.c. is investigating  GlobeNewswire Fri, 26 Jul 2024 01:00:00 GMT
 biogen alert: bragar eagel & squire, p.c. is investigating  GlobeNewswire Thu, 25 Jul 2024 07:00:00 GMT
 Geron losing commercial chief shortly after first FDA approval  Fierce Pharma Wed, 24 Jul 2024 07:00:00 GMT
 chronic kidney disease fda approvals, emerging drugs,  openPR Tue, 16 Jul 2024 10:14:00 GMT
 friedreich's ataxia market to grow at a substantial growth  GlobeNewswire Tue, 16 Jul 2024 07:00:00 GMT
 key takeaways from biogen analyst ratings  Quantisnow Fri, 12 Jul 2024 15:00:43 GMT
 why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report?  Yahoo News Australia Wed, 10 Jul 2024 18:09:02 GMT
 reata pharmaceuticals | biotechnology | the pharmaletter  The Pharma Letter Fri, 05 Jul 2024 11:19:19 GMT
 chronic kidney disease pipeline 2024 | boehringer ingelheim,  openPR Wed, 03 Jul 2024 10:13:00 GMT
 biogen completes acquisition of human immunology biosciences  Quantisnow Tue, 02 Jul 2024 13:29:03 GMT
 why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report?  Yahoo News Australia Mon, 01 Jul 2024 14:21:50 GMT
 why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report?  Yahoo News Australia Sun, 30 Jun 2024 01:20:00 GMT
 reata (reta) omaveloxolone program faces delay on fda update  Yahoo Movies UK Sat, 29 Jun 2024 20:19:49 GMT
 why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report?  Yahoo News Australia Fri, 28 Jun 2024 09:33:45 GMT
 reata (reta) confirms omaveloxolone nda filing in q1 2022  Yahoo New Zealand News Fri, 28 Jun 2024 01:26:00 GMT
 pharma m&a: the top high value deals in 2023  Pharmaceutical Technology Wed, 26 Jun 2024 07:00:00 GMT
 Top 10 smartest deals in biopharma  Fierce Biotech Mon, 24 Jun 2024 07:00:00 GMT
 friedreich ataxia  Biogen Mon, 17 Jun 2024 21:05:18 GMT
 reata pharmaceuticals, inc. (reta) moves 7.0% higher: will this strength last?  Yahoo News Australia Wed, 12 Jun 2024 02:21:05 GMT
 reata pharmaceuticals, inc. (nasdaq:reta): when will it breakeven?  Yahoo Movies UK Fri, 07 Jun 2024 07:16:52 GMT
 reata pharmaceuticals, inc. (reta) stock jumps 20.6%: will it continue to soar?  Yahoo New Zealand News Fri, 31 May 2024 04:37:00 GMT
 why is reata pharmaceuticals, inc. (reta) up 53.1% since last earnings report?  Yahoo Sport Australia Thu, 30 May 2024 18:03:28 GMT
 events & presentations | biogen  Biogen | Investor Relations Thu, 30 May 2024 06:36:52 GMT
 presentations  Biogen | Investor Relations Thu, 30 May 2024 06:36:52 GMT
 reata pharmaceuticals, inc. (reta) reports q2 loss, tops revenue estimates  Yahoo Singapore News Wed, 29 May 2024 07:12:42 GMT
 reata pharmaceuticals, inc. (reta) stock jumps 20.6%: will it continue to soar?  Yahoo New Zealand News Tue, 28 May 2024 22:02:58 GMT
 is reata pharmaceuticals, inc.'s (nasdaq:reta) ceo pay fair?  Yahoo Lifestyle UK Sun, 26 May 2024 18:08:54 GMT
 reata pharmaceuticals, inc. (reta) reports q4 loss, lags revenue estimates  Yahoo Lifestyle Australia Sat, 25 May 2024 00:47:00 GMT
 reata (reta) jumps: stock rises 5. 6%  Yahoo News Australia Fri, 24 May 2024 17:34:24 GMT
 stifel downgrades reata pharmaceuticals inc - (reta)  MSN Wed, 22 May 2024 09:07:23 GMT
 full steam ahead for friedreich's ataxia-focused larimar  The Pharma Letter Wed, 22 May 2024 07:00:00 GMT
 larimar resumes nomlabofusp programme after fda lifts partial hold  Clinical Trials Arena Tue, 21 May 2024 07:00:00 GMT
 reata pharmaceuticals, inc. (reta) reports q4 loss, lags revenue estimates  Yahoo Lifestyle Australia Mon, 20 May 2024 00:37:31 GMT
 reata pharmaceuticals, inc. (reta) reports q1 loss, lags revenue estimates  Yahoo Canada Shine On Sat, 18 May 2024 22:35:03 GMT
 intel, reata pharma and roku rally, and other movers  MSN Fri, 17 May 2024 10:20:22 GMT
 earnings preview: reata pharmaceuticals, inc. (reta) q3 earnings expected to decline  Yahoo Lifestyle Australia Thu, 16 May 2024 23:57:08 GMT
 biogen ceo looks for small deals while alzheimer’s drug ramps up  themiddlemarket.com Thu, 16 May 2024 07:00:00 GMT
 biogen ceo looks for small deals while alzheimer's drug ramps up  Bloomberg Thu, 16 May 2024 07:00:00 GMT
 reata (reta) up more than 12% ytd: what's driving the rally?  Yahoo Movies Canada Mon, 13 May 2024 14:24:35 GMT
 why is reata pharmaceuticals, inc. (reta) up 6.9% since last earnings report?  Yahoo Movies Canada Mon, 13 May 2024 02:53:48 GMT
 rare diseases - bardoxolone, nephrology and hepatology  The Pharma Letter Sun, 12 May 2024 01:46:30 GMT
 rare diseases - bardoxolone, cns diseases  The Pharma Letter Sun, 12 May 2024 01:45:27 GMT
 rare diseases - nephrology and hepatology, bardoxolone  The Pharma Letter Sat, 11 May 2024 18:08:49 GMT
 one to watch companies - us fda, vyjuvek  The Pharma Letter Sat, 11 May 2024 17:47:17 GMT
 reata pharmaceuticals reports q1 loss per share of $0.32  Reuters Sat, 11 May 2024 07:00:00 GMT
 reata pharmaceuticals, inc. (reta) reports q4 loss, lags revenue estimates  Yahoo Canada Shine On Fri, 10 May 2024 01:20:00 GMT
 one to watch companies - us fda, fyarro, reata pharmaceuticals  The Pharma Letter Wed, 08 May 2024 23:36:46 GMT
 one to watch companies - us fda, voclosporin  The Pharma Letter Tue, 07 May 2024 10:26:25 GMT
 focus on - drug trial, anti-arthritics/rheumatics, bardoxolone  The Pharma Letter Mon, 06 May 2024 23:15:28 GMT
 focus on - licensing, astrazeneca, bardoxolone  The Pharma Letter Mon, 06 May 2024 20:44:39 GMT
 focus on - bayer, oncology, reata pharmaceuticals  The Pharma Letter Mon, 06 May 2024 19:15:17 GMT
 aacr annual meeting 2018 - rare diseases, bardoxolone  The Pharma Letter Mon, 06 May 2024 10:51:38 GMT
 u.s. fda approves reata's rare genetic disorder drug  Yahoo Movies Canada Sun, 05 May 2024 14:13:48 GMT
 reata pharmaceuticals, inc. (reta) stock jumps 20.6%: will it continue to soar?  Yahoo Singapore News Sun, 05 May 2024 12:16:01 GMT
 reata (reta) q1 earnings surpass estimates, revenues miss  Yahoo Lifestyle UK Sat, 04 May 2024 16:14:14 GMT
 reata (reta) q2 earnings miss, revenues down y/y, stock down  Yahoo New Zealand News Fri, 03 May 2024 05:09:27 GMT
 biopharma layoffs roundup  Contract Pharma Fri, 26 Apr 2024 07:00:00 GMT
 biogen reports net income of $393.4m in q1 2024  Pharmaceutical Technology Thu, 25 Apr 2024 07:00:00 GMT
 biogen stock surges after two notable products walloped sales expectations  Investor's Business Daily Wed, 24 Apr 2024 07:00:00 GMT
 biogen stock climbs on strong alzheimer’s drug sales  The Boston Globe Wed, 24 Apr 2024 07:00:00 GMT
 biogen profit beats street estimates as cost-cutting takes hold  Bloomberg Wed, 24 Apr 2024 07:00:00 GMT
 pharmaceutical technology  Pharmaceutical Technology Mon, 22 Apr 2024 07:29:51 GMT
 fda approves skyclarys for friedreich’s ataxia  Specialty Pharmacy Continuum Fri, 19 Apr 2024 04:59:08 GMT
 fda approves skyclarys for friedreich's ataxia  Specialty Pharmacy Continuum Fri, 19 Apr 2024 04:59:08 GMT
 reata pharma off 13% after insider selling  MSN Thu, 18 Apr 2024 03:56:56 GMT
 lexeo wins fast track designation for friedreich’s ataxia gene therapy  Pharmaceutical Technology Wed, 17 Apr 2024 07:00:00 GMT
 biogen ceo's 2023 pay shrank by 87%  FiercePharma Tue, 16 Apr 2024 07:00:00 GMT
 why reata (reta) stock might be a great pick  Yahoo Movies Canada Mon, 15 Apr 2024 14:55:05 GMT
 249 - 20 years in the making: reata's story of skyclarys  Audacy Mon, 15 Apr 2024 07:00:00 GMT
 can the uptrend continue for reata pharmaceuticals (reta)?  Yahoo Movies UK Thu, 11 Apr 2024 03:08:13 GMT
 biopharma layoffs roundup  Contract Pharma Wed, 10 Apr 2024 20:03:26 GMT
 biopharma layoffs roundup  Contract Pharma Thu, 28 Mar 2024 04:58:46 GMT
 biopharma layoffs roundup  Contract Pharma Wed, 27 Mar 2024 07:00:00 GMT
 reata pharmaceuticals, inc. (nasdaq:reta): are analysts optimistic?  Yahoo News Australia Mon, 18 Mar 2024 21:39:37 GMT
 reata pharmaceuticals, inc. (nasdaq:reta): are analysts optimistic?  Yahoo News Australia Sat, 16 Mar 2024 05:17:14 GMT
 biogen's top dealmaker is keen on rare disease meds  Fierce Biotech Tue, 05 Mar 2024 08:00:00 GMT
 larimar lays out fda approval plan for friedreich's ataxia drug  GlobalData Sun, 03 Mar 2024 06:54:34 GMT
 reata's (reta) skyclarys pas gets fda nod, stock rises 7%  Yahoo Singapore News Fri, 01 Mar 2024 02:28:42 GMT
 10 multibillion-dollar m&as that closed since july 2023  BioSpace Wed, 21 Feb 2024 08:00:00 GMT
 stockwatch: biogen’s q4 results disappoint analysts  Genetic Engineering & Biotechnology News Sun, 18 Feb 2024 08:00:00 GMT
 larimar lays out fda approval plan for friedreich’s ataxia drug  Clinical Trials Arena Tue, 13 Feb 2024 08:00:00 GMT
 biogen's rare genetic disorder drug gets approval in eu  ETHealthWorld Tue, 13 Feb 2024 08:00:00 GMT
 larimar lays out fda approval plan for friedreich's ataxia drug  Clinical Trials Arena Tue, 13 Feb 2024 08:00:00 GMT
 ec nod for biogen's skyclarys for friedreich's ataxia  The Pharma Letter Tue, 13 Feb 2024 08:00:00 GMT
 ec nod for biogen’s skyclarys for friedreich’s ataxia  The Pharma Letter Tue, 13 Feb 2024 08:00:00 GMT
 biogen's rare genetic disorder drug gets approval in eu  Reuters.com Mon, 12 Feb 2024 08:00:00 GMT
 eu clears biogen's skyclarys for friedreich's ataxia  FirstWord Pharma Mon, 12 Feb 2024 08:00:00 GMT
 The top 10 biopharma M&A deals of 2023  Fierce Pharma Mon, 05 Feb 2024 08:00:00 GMT
 pharmaceutical technology  Pharmaceutical Technology Thu, 01 Feb 2024 21:00:54 GMT
 biogen drops aduhelm efforts after controversial speedy approval  FiercePharma Wed, 31 Jan 2024 08:00:00 GMT
 Friedreich Ataxia  Biogen Thu, 18 Jan 2024 20:13:09 GMT
 reata pharmaceuticals, inc. (reta) moves 7.0% higher: will this strength last?  Yahoo News Australia Tue, 09 Jan 2024 18:55:14 GMT
 pharmaceutical technology  Pharmaceutical Technology Wed, 20 Dec 2023 08:00:00 GMT
 european regulators push biogen, crispr drugs toward approval  BioPharma Dive Fri, 15 Dec 2023 08:00:00 GMT
 biogen's skyclarys backed by eu panel for friedreich's ataxia  FirstWord Pharma Fri, 15 Dec 2023 08:00:00 GMT

Reata Pharmaceuticals, Inc
(NASDAQ:RETA) 

RETA stock logo

Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs,...

Founded: 2002
Full Time Employees: 220
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends